SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-22-000007
Filing Date
2022-01-20
Accepted
2022-01-20 17:53:50
Documents
2
Period of Report
2022-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164271921610822.html 4  
1 FORM 4 wf-form4_164271921610822.xml 4 3908
2 POA - MCELHAUGH poa-mcelhaugh.htm EX-24 3343
  Complete submission text file 0001447028-22-000007.txt   8821
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
McElhaugh Michael J. (Reporting) CIK: 0001635326 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 22543379